Striatal dopamine D2-receptor blockade by typical and atypical neuroleptics-Reference-Cited by-同舟云学术

Striatal dopamine D2-receptor blockade by typical and atypical neuroleptics

Published:1992-02 Issue:8791 Volume:339 Page:497
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Brücke T.,Roth J.,Podreka I.,Strobl R.,Wenger S.,Asenbaum S.

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders;Brücke;J Cereb Blood Flow Metab,1991

2. Dopamine receptor imaging with SPECT: a diagnostic tool in extrapyramidal disorders and in vivo assay for the measurement of receptor blockade by neuroleptic treatment;Brucke;J Cereb Blood Flow Metab,1991

3. Molecular cloning and characterisation of a novel dopamine receptor (D3) as a target for neuroleptics;Sokoloff;Nature,1990

4. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine;Van Tol;Nature,1991

5. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1;Sunahara;Nature,1991

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Treatment of Cognitive and Behavioral Disorders in Dementia;Practical Issues in Geriatrics;2023

2. The Role of Dopamine in Temporal Uncertainty;Journal of Cognitive Neuroscience;2016-01-01

3. Glutamate and dopamine in schizophrenia: An update for the 21st century;Journal of Psychopharmacology;2015-01-13

4. IBZM SPECT and FDG PET in the differential diagnosis of Parkinsonian syndromes;Nuklearmedizin;2010

5. Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging;Current Pharmaceutical Design;2009-08-01